Development and Feasibility Testing of an Advanced Practice Physiotherapy Role in Chronic Pain Management
1 other identifier
interventional
45
1 country
2
Brief Summary
The current study is intended to evaluate the feasibility of conducting a future trial to evaluate the effects of implementing an advanced practice physiotherapist (APP) role within a chronic pain clinic setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable chronic-pain
Started Jun 2022
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2022
CompletedFirst Posted
Study publicly available on registry
April 20, 2022
CompletedStudy Start
First participant enrolled
June 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedMarch 20, 2025
March 1, 2025
1.5 years
April 5, 2022
March 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Participant recruitment
Recruitment rate (participants/week) over 8 weeks.
Baseline to 8 weeks
Assessment completion
Proportion of all assessment items completed over the study duration (includes assessment items from baseline and 3, 6, 9, and 12 months follow-up)
12 months
Duration of baseline survey completion
Mean time to complete the baseline survey
Baseline
Duration of follow-up survey completion
Mean time to complete follow-up surveys (includes surveys at 3, 6, 9, and 12 months)
12 months
Participant attrition
Attrition of participants expressed as a percentage lost to follow-up at 12 months.
12 months
Transfer of care
Percentage of cases where the APP can successfully fulfill the role without having to transfer care to a physician or nurse practitioner as the most responsible provider.
Baseline to 8 weeks
Treatment fidelity
Fidelity checklist for the APP intervention. Percentage of red flags screened for and percentage completion of all other assessment items.
Baseline to 8 weeks
Participant perspectives
Semi-structured interviews with participants involved in the study to explore acceptability of and satisfaction with the APP model of care.
1-2 months after visit with APP
Health care provider perspectives
Semi-structured interviews with health care providers involved in the study to explore acceptability of and satisfaction with the APP model of care.
1-2 months after visit with APP
Secondary Outcomes (13)
Brief Pain Inventory - pain severity subscale
Baseline and 3, 6, 9, and 12 months follow-up
Brief Pain Inventory - pain interference subscale
Baseline and 3, 6, 9, and 12 months follow-up
Health-related quality of life
Baseline and 3, 6, 9, and 12 months follow-up
Pain Catastrophizing Scale
Baseline and 3, 6, 9, and 12 months follow-up
Tampa Scale of Kinesiophobia
Baseline and 3, 6, 9, and 12 months follow-up
- +8 more secondary outcomes
Other Outcomes (2)
Baseline measures
Baseline
Comorbidities
Baseline
Study Arms (1)
APP-led model of care for chronic pain management
EXPERIMENTALThe APP-led model of care involves integrating an APP as the first point of contact within an interprofessional chronic pain clinic setting. This is in contrast to the usual physician- or nurse practitioner-led model of care.
Interventions
The APP will provide an assessment using a biopsychosocial approach. The assessment will include: * taking a comprehensive history * screening for pathologies contributing to the participant's chronic pain * a physical assessment * screening for comorbid health conditions, using the appropriate screening tools, that require specific care (e.g., depression, addiction, post-traumatic stress) * identifying psychosocial risk factors associated with pain and disability * evaluating pain severity and interference The APP will make recommendations to the participant and the chronic pain clinic health care team based on findings from the comprehensive assessment. These recommendations include, but are not limited to, the need for urgent or emergent referrals, medication management, referral and integration of other health care providers, the need for interventional procedures, or group-based treatment options.
Eligibility Criteria
You may qualify if:
- Chronic musculoskeletal pain (pain \> 3 months in duration) (e.g., neck pain, thoracic pain, limb pain, low back pain) -OR-
- Chronic widespread pain (e.g., fibromyalgia, myofascial syndrome) -AND-
- years of age or older -AND-
- Must be able to read, write, and speak English
You may not qualify if:
- Primary reason for referral stated as medication change or interventional pain management (e.g., injections, nerve block)
- Primary reason for referral is stated as headache or migraine.
- Reason for referral is chronic pelvic pain
- Referral includes information that patient has an untreated addiction, mental health disorder, or substance use disorder
- Referral indicates cancer-related pain
- Referral indicates medical "red flags" suggestive of non-musculoskeletal etiology of symptoms (e.g., unexplained symptoms, sudden weight loss, urinary retention, saddle anesthesia, evidence of upper motor neuron lesion, or fever)
- Referral states visceral pain or abdominal pain.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Kingston Health Sciences Center, Hotel Dieu site - Chronic Pain Clinic
Kingston, Ontario, K7L 3N6, Canada
Queen's University
Kingston, Ontario, K7L 3N6, Canada
Related Publications (1)
Miller J, Doulas T, Bisson EJ, Abebe A, Chala M, McClintock C, Varette K, Vader K, Desmeules F, Perreault K, Donnelly C, Booth R, Tawiah AK, Duggan S. Assessing the feasibility of a clinical trial to evaluate an advanced practice physiotherapy model of care in chronic pain management: a feasibility study. Pilot Feasibility Stud. 2023 Jul 17;9(1):125. doi: 10.1186/s40814-023-01352-9.
PMID: 37461072DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jordan Miller, PhD
Queen's University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Participants will be invited to participate in the study with an understanding that they will be assigned to either a model of care in which they see the physician or nurse practitioner first or a model of care in which they see a physiotherapist first, even though this is a single arm feasibility study and all participants will be assigned to the APP model of care. This partial masking at the time of consent and initial assessment was determined to be important to provide accurate estimates of feasibility (e.g. consent rate, percentage of consenting participants who see the physiotherapist first who also request to see the physician or nurse practitioner). Due to the nature of the intervention, participants and healthcare providers will not be blinded to the intervention received in this or the fully powered trial. Since the primary outcome measures are self-report measures (ie. the participant is the assessor), the outcome assessor is similarly not planned to be blinded.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor, School of Rehabilitation Therapy, Queen's University
Study Record Dates
First Submitted
April 5, 2022
First Posted
April 20, 2022
Study Start
June 24, 2022
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
March 20, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share IPD with other researchers.